Disease Studies

PrecisionLife announces first close of Series A financing to progress its drug discovery pipeline and commercial partnerships

OXFORD, UK January 31, 2022 – PrecisionLife announces the first close of its Series A investment round.

Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.